Oxidative Stress and Inflammation Biomarker Expression in Obstructive Sleep Apnea Patients
- PMID: 33451164
- PMCID: PMC7828672
- DOI: 10.3390/jcm10020277
Oxidative Stress and Inflammation Biomarker Expression in Obstructive Sleep Apnea Patients
Abstract
Obstructive Sleep Apnea Syndrome (OSAS) is a respiratory sleep disorder characterised by repeated episodes of partial or complete obstruction of the upper airway during the night. This obstruction usually occurs with a reduction (hypopnea) or complete cessation (apnea) of the airflow in the upper airways with the persistence of thoracic-diaphragmatic respiratory movements. During the hypopnea/apnea events, poor alveolar ventilation reduces the oxygen saturation in the arterial blood (SaO2) and a gradual increase in the partial arterial pressure of carbon dioxide (PaCO2). The direct consequence of the intermittent hypoxia is an oxidative imbalance, with reactive oxygen species production and the inflammatory cascade's activation with pro and anti-inflammatory cytokines growth. Tumour necrosis factors, inflammatory cytokines (IL2, IL4, IL6), lipid peroxidation, and cell-free DNA have been found to increase in OSAS patients. However, even though different risk-related markers have been described and analysed in the literature, it has not yet been clarified whether specified inflammatory bio-markers better correlates with OSAS diagnosis and its clinical evolution/comorbidities. We perform a scientific literature review to discuss inflammatory and oxidative stress biomarkers currently tested in OSAS patients and their correlation with the disease's severity and treatment.
Keywords: cardiovascular risk; cell-free DNA; intermittent hypoxia; lipid peroxidation; obstructive sleep apnea; tumour necrosis factors.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

References
-
- Kapur V.K., Auckley D.H., Chowdhuri S., Kuhlmann D.C., Mehra R., Ramar K., Harrod C.G. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J. Clin. Sleep Med. 2017;13:479–504. doi: 10.5664/jcsm.6506. - DOI - PMC - PubMed
-
- Paruthi S., Rosen C.L., Wang R., Weng J., Marcus C.L., Chervin R.D., Stanley J.J., Katz E.S., Amin R., Redline S. End-Tidal Carbon Dioxide Measurement during Pediatric Polysomnography: Signal Quality, Association with Apnea Severity, and Prediction of Neurobehavioral Outcomes. Sleep. 2015;38:1719–1726. doi: 10.5665/sleep.5150. - DOI - PMC - PubMed
-
- Drager L.F., McEvoy R.D., Barbe F., Lorenzi-Filho G., Redline S. INCOSACT Initiative (International Collaboration of Sleep Apnea Cardiovascular Trialists). Sleep Apnea and Cardiovascular Disease: Lessons from Recent Trials and Need for Team Science. Circulation. 2017;136:1840–1850. doi: 10.1161/CIRCULATIONAHA.117.029400. - DOI - PMC - PubMed
-
- Iannella G., Maniaci A., Magliulo G., Cocuzza S., La Mantia I., Cammaroto G., Greco A., Vicini C. Current challenges in the diagnosis and treatment of obstructive sleep apnea syndrome in the elderly [published online ahead of print, 2020 Apr 6] Pol. Arch. Intern. Med. 2020 doi: 10.20452/pamw.15283. - DOI - PubMed
Publication types
LinkOut - more resources
Other Literature Sources